“…This antigenindependent TCR nanoclustering (Lillemeier et al, 2010, Schamel & Alarcon, 2013, Schamel et al, 2005, Schamel et al, 2006, Sherman et al, 2011 enhances antigenic sensitivity by increasing avidity to multimeric peptide-major histocompatibility complexes (Kumar et al, 2011, Molnar et al, 2012 and by allowing cooperativity between TCR molecules (Martín-Blanco et al, 2018, Martínez-Martín et al, 2009. TCRβ subunit interaction with cholesterol (Chol) and the presence of sphingomyelins (SM) are both essential for TCR nanoclustering (Beck-Garcia et al, 2015, Molnar et al, 2012. Replacement of Chol by Chol sulfate impedes TCR nanocluster formation and reduces CD4 + CD8 + thymocyte sensitivity to weak antigenic peptides (Wang et al, 2016).…”